Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Sanda

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the InternetN Kamo, S V Dandapani, R A Miksad, et al.
The Journal of Urology|March 1, 1997
Clinical and biological characteristics of familial benign prostatic hyperplasiaM G Sanda, C B Doehring, B Binkowitz, et al.
Urology|February 5, 1999
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancerM G Sanda, D C Smith, L G Charles, et al.
Journal of the National Cancer Institute|January 29, 1999
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigenY C Xie, C Hwang, W Overwijk, et al.
Urology|December 22, 1999
Early castration reduces prostatic carcinogenesis in transgenic miceM H Eng, L G Charles, B D Ross, et al.
Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
The Journal of Urology|September 29, 1998
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic miceC X Hsu, B D Ross, C E Chrisp, et al.
The Journal of Urology|March 1, 1994
Demonstration of a rational strategy for human prostate cancer gene therapyM G Sanda, S R Ayyagari, E M Jaffee, et al.
Journal of the National Cancer Institute|January 5, 1994
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancerD J Cole, M G Sanda, J C Yang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2010
Evaluation of the SCA instrument for measuring patient satisfaction with cancer care administered via paper or via the InternetN Kamo, S V Dandapani, R A Miksad, et al.
The Journal of Urology|March 1, 1997
Clinical and biological characteristics of familial benign prostatic hyperplasiaM G Sanda, C B Doehring, B Binkowitz, et al.
Urology|February 5, 1999
Recombinant vaccinia-PSA (PROSTVAC) can induce a prostate-specific immune response in androgen-modulated human prostate cancerM G Sanda, D C Smith, L G Charles, et al.
Journal of the National Cancer Institute|January 29, 1999
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigenY C Xie, C Hwang, W Overwijk, et al.
Urology|December 22, 1999
Early castration reduces prostatic carcinogenesis in transgenic miceM H Eng, L G Charles, B D Ross, et al.
Urology|October 1, 1996
Histopathologic characterization of hereditary benign prostatic hyperplasiaC B Doehring, M G Sanda, A W Partin, et al.
Urology|May 1, 1995
Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyA W Partin, S Piantadosi, M G Sanda, et al.
The Journal of Urology|September 29, 1998
Longitudinal cohort analysis of lethal prostate cancer progression in transgenic miceC X Hsu, B D Ross, C E Chrisp, et al.
The Journal of Urology|March 1, 1994
Demonstration of a rational strategy for human prostate cancer gene therapyM G Sanda, S R Ayyagari, E M Jaffee, et al.
Journal of the National Cancer Institute|January 5, 1994
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancerD J Cole, M G Sanda, J C Yang, et al.
Pageof 4